(AKAO) - Earnings & Price History

AKAO: - 12.69, $540.27M, -0.03 (-0.24%)

Sector: Healthcare - Industry: Biotechnology

Achaogen, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antibacterials to treat multi-drug resistant (MDR) gram-negative infections in the United States. The company is principally developing plazomicin, which is in Phase III clinical trial for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. It is also involved in the research and development of antipseudomonal LpxC inhibitor compounds that target infections caused by acinetobacter baumannii and pseudomonas aeruginosa; and therapeutic antibody discovery program. The company has development services agreement with ARK Diagnostics, Inc. to co-develop an in vitro assay to measure levels of plazomicin in the blood to enable patients to receive safe and efficacious doses of plazomicin; and license agreement with Ionis Ph

Past AKAO reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2014-11-10Achogen Inc-0.18-0.4710.079.889.98910.151.01%0.90%1.92%19.50K
2014-08-11Achogen Inc-0.19-0.29.8710.1410.139.810.71-0.10%▲-2.57%-2.66%84.10K

Login | Register
Saturday Aug 17, 2019   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR


index chart
index color